↓ Skip to main content

Home versus in-patient treatment for deep vein thrombosis

Overview of attention for article published in Cochrane database of systematic reviews, July 2007
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Home versus in-patient treatment for deep vein thrombosis
Published in
Cochrane database of systematic reviews, July 2007
DOI 10.1002/14651858.cd003076.pub2
Pubmed ID
Authors

Richard Othieno, Mayada Abu Affan, Emmanuel Okpo

Abstract

Deep vein thrombosis (DVT) occurs when a blood clot blocks blood flow through a vein. This can happen after surgery, trauma, or when a person has been immobile. Clots can dislodge and block blood flow to the lungs, causing death. Heparin is a blood-thinning drug used in the first 3-5 days of DVT treatment. Low molecular weight heparins (LMWH) allow people with DVT to receive their initial treatment at home instead of in hospital.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Russia 1 2%
Canada 1 2%
Unknown 52 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 17%
Student > Master 8 15%
Student > Doctoral Student 7 13%
Other 7 13%
Student > Ph. D. Student 6 11%
Other 14 26%
Unknown 3 6%
Readers by discipline Count As %
Medicine and Dentistry 32 59%
Psychology 5 9%
Nursing and Health Professions 3 6%
Economics, Econometrics and Finance 3 6%
Computer Science 1 2%
Other 4 7%
Unknown 6 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2014.
All research outputs
#10,023,988
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,204
of 8,923 outputs
Outputs of similar age
#127,277
of 189,367 outputs
Outputs of similar age from Cochrane database of systematic reviews
#181
of 189 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,367 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 189 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.